2021 儿童静脉注射阿奇霉素超说明书用药建议

2021-01-09 中国儿科相关医学专家组(统称) Int J Clin Pract . 2021 Jan 9.

静脉注射阿奇霉素(AZM)在全世界范围内广泛用于儿童患者,但仍有很多关于该药的超说明书用药担忧。本文由中国专家制定,主要针对儿童静脉注射阿奇霉素超说明书用药提供指导建议,共涉及18条推荐意见,涵盖了4

中文标题:

2021 儿童静脉注射阿奇霉素超说明书用药建议

英文标题:

Recommendations on off-label use of intravenous azithromycin in children

发布日期:

2021-01-09

简要介绍:

静脉注射阿奇霉素(AZM)在全世界范围内广泛用于儿童患者,但仍有很多关于该药的超说明书用药担忧。本文由中国专家制定,主要针对儿童静脉注射阿奇霉素超说明书用药提供指导建议,共涉及18条推荐意见,涵盖了4个方面,分别为适应症,用法用量,不良反应及处理以及特殊人群用药。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 儿童静脉注射阿奇霉素超说明书用药建议.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0b2d41c0020a38c5, title=2021 儿童静脉注射阿奇霉素超说明书用药建议, enTitle=Recommendations on off-label use of intravenous azithromycin in children, guiderFrom=Int J Clin Pract . 2021 Jan 9., authorId=0, author=, summary=静脉注射阿奇霉素(AZM)在全世界范围内广泛用于儿童患者,但仍有很多关于该药的超说明书用药担忧。本文由中国专家制定,主要针对儿童静脉注射阿奇霉素超说明书用药提供指导建议,共涉及18条推荐意见,涵盖了4, cover=https://img.medsci.cn/2021127/1611757641999_2020535.jpg, journalId=0, articlesId=null, associationId=924, associationName=中国儿科相关医学专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Sat Jan 09 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>静脉注射阿奇霉素(AZM)在全世界范围内广泛用于儿童患者,但仍有很多关于该药的超说明书用药担忧。本文由中国专家制定,主要针对儿童静脉注射阿奇霉素超说明书用药提供指导建议,共涉及18条推荐意见,涵盖了4个方面,分别为适应症,用法用量,不良反应及处理以及特殊人群用药。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2266, tagName=阿奇霉素)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2266, guiderKeyword=阿奇霉素, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=19408, appHits=190, showAppHits=0, pcHits=1575, showPcHits=19213, likes=3, shares=17, comments=8, approvalStatus=1, publishedTime=Wed Jan 27 22:40:22 CST 2021, publishedTimeString=2021-01-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Jan 27 22:27:32 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:30:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 儿童静脉注射阿奇霉素超说明书用药建议.pdf)])
2021 儿童静脉注射阿奇霉素超说明书用药建议.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1079214, encodeId=5b5e10e92147a, content=看不懂。 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51926398305, createdName=ms8000001039650582, createdTime=Sun Dec 12 10:11:44 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074596, encodeId=295110e459604, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 20:17:07 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977548, encodeId=97759e75480f, content=很有临床指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1855535738, createdName=明月清风1, createdTime=Mon Jun 28 11:54:42 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967937, encodeId=703196e93765, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/0e688fd3cd65927b404946771fd2f2e1.jpg, createdBy=34002437499, createdName=醉羊, createdTime=Sun May 23 16:09:32 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960670, encodeId=bf669606e008, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 16:02:14 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-12-12 ms8000001039650582

    看不懂。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1079214, encodeId=5b5e10e92147a, content=看不懂。 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51926398305, createdName=ms8000001039650582, createdTime=Sun Dec 12 10:11:44 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074596, encodeId=295110e459604, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 20:17:07 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977548, encodeId=97759e75480f, content=很有临床指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1855535738, createdName=明月清风1, createdTime=Mon Jun 28 11:54:42 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967937, encodeId=703196e93765, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/0e688fd3cd65927b404946771fd2f2e1.jpg, createdBy=34002437499, createdName=醉羊, createdTime=Sun May 23 16:09:32 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960670, encodeId=bf669606e008, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 16:02:14 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-11-27 ms8000001755238620

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1079214, encodeId=5b5e10e92147a, content=看不懂。 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51926398305, createdName=ms8000001039650582, createdTime=Sun Dec 12 10:11:44 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074596, encodeId=295110e459604, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 20:17:07 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977548, encodeId=97759e75480f, content=很有临床指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1855535738, createdName=明月清风1, createdTime=Mon Jun 28 11:54:42 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967937, encodeId=703196e93765, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/0e688fd3cd65927b404946771fd2f2e1.jpg, createdBy=34002437499, createdName=醉羊, createdTime=Sun May 23 16:09:32 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960670, encodeId=bf669606e008, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 16:02:14 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-06-28 明月清风1

    很有临床指导意义

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1079214, encodeId=5b5e10e92147a, content=看不懂。 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51926398305, createdName=ms8000001039650582, createdTime=Sun Dec 12 10:11:44 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074596, encodeId=295110e459604, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 20:17:07 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977548, encodeId=97759e75480f, content=很有临床指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1855535738, createdName=明月清风1, createdTime=Mon Jun 28 11:54:42 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967937, encodeId=703196e93765, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/0e688fd3cd65927b404946771fd2f2e1.jpg, createdBy=34002437499, createdName=醉羊, createdTime=Sun May 23 16:09:32 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960670, encodeId=bf669606e008, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 16:02:14 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-05-23 醉羊

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1079214, encodeId=5b5e10e92147a, content=看不懂。 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51926398305, createdName=ms8000001039650582, createdTime=Sun Dec 12 10:11:44 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074596, encodeId=295110e459604, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 20:17:07 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977548, encodeId=97759e75480f, content=很有临床指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1855535738, createdName=明月清风1, createdTime=Mon Jun 28 11:54:42 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967937, encodeId=703196e93765, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/0e688fd3cd65927b404946771fd2f2e1.jpg, createdBy=34002437499, createdName=醉羊, createdTime=Sun May 23 16:09:32 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960670, encodeId=bf669606e008, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 16:02:14 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-04-26 ms9000001532925281

    学习了

    0